Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:665-671

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoshiya, M.
Right arrow Articles by Awazu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoshiya, M.
Right arrow Articles by Awazu, M.

(Hypertension. 1998;31:665-671.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Trapidil Inhibits Platelet-Derived Growth Factor–Stimulated Mitogen-Activated Protein Kinase Cascade

Makiko Hoshiya; ; Midori Awazu

From the Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

Correspondence to Midori Awazu, MD, Department of Pediatrics, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan. E-mail awazu{at}mc.med.keio.ac.jp

Abstract—Trapidil, an antiplatelet drug, has been shown to reduce restenosis after angioplasty. It exerts its action, at least in part, by inhibiting vascular smooth muscle cell proliferation, antagonizing platelet-derived growth factor (PDGF). We examined its site of action on PDGF cellular signaling. Exposure of cultured rat vascular smooth muscle cells to increasing concentrations of trapidil for 18 hours resulted in a dose-dependent reduction in PDGF-BB–stimulated [3H] thymidine incorporation. Trapidil (400 µg/mL) increased PDGF ß-receptor protein by 28±8%, whereas PDGF-induced tyrosine phosphorylation of PDGF ß-receptor remained unchanged. PDGF-induced tyrosine phosphorylation of phospholipase C{gamma}, the p85 regulatory subunit of phosphatidyl-inositol 3 kinase, Ras GTPase–activating protein, and an adaptor molecule Shc were also not altered. On the other hand, trapidil inhibited PDGF-stimulated mitogen-activated protein kinase (MAP kinase) activity by 35±7% at 10 minutes and by 32±10% at 6 hours. Activation of Raf-1, an upstream activator of MAP kinase, by PDGF was also attenuated by trapidil. Moreover, protein content of MAP kinase phosphatase-1, which inactivates MAP kinase, was elevated in trapidil-treated cells. These actions of trapidil may be mediated by cAMP. Thus, there was a 1.9-fold increase in cellular cAMP generation in trapidil-treated cells. The present results demonstrate that trapidil antagonizes PDGF-induced mitogenesis and MAP kinase activation in vascular smooth muscle cells, probably through cAMP.


Key Words: trapidil • growth factors, platelet-derived • restenosis • kinases • mitogenesis • cyclic AMP




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
C. V. Garat, D. Fankell, P. F. Erickson, J. E.-B. Reusch, N. N. Bauer, I. F. McMurtry, and D. J. Klemm
Platelet-Derived Growth Factor BB Induces Nuclear Export and Proteasomal Degradation of CREB via Phosphatidylinositol 3-Kinase/Akt Signaling in Pulmonary Artery Smooth Muscle Cells.
Mol. Cell. Biol., July 1, 2006; 26(13): 4934 - 4948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Klemm, P. A. Watson, M. G. Frid, E. C. Dempsey, J. Schaack, L. A. Colton, A. Nesterova, K. R. Stenmark, and J. E.-B. Reusch
cAMP Response Element-binding Protein Content Is a Molecular Determinant of Smooth Muscle Cell Proliferation and Migration
J. Biol. Chem., November 30, 2001; 276(49): 46132 - 46141.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Goetze, X.-P. Xi, Y. Kawano, H. Kawano, E. Fleck, W. A. Hsueh, and R. E. Law
TNF-{alpha}–Induced Migration of Vascular Smooth Muscle Cells Is MAPK Dependent
Hypertension, January 1, 1999; 33(1): 183 - 189.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Bönisch, A.-A. Weber, M. Wittpoth, M. Osinski, and K. Schrör
Antimitogenic Effects of Trapidil In Coronary Artery Smooth Muscle Cells by Direct Activation of Protein Kinase A
Mol. Pharmacol., August 1, 1998; 54(2): 241 - 248.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Goetze, U. Kintscher, H. Kawano, Y. Kawano, S. Wakino, E. Fleck, W. A. Hsueh, and R. E. Law
Tumor Necrosis Factor alpha Inhibits Insulin-induced Mitogenic Signaling in Vascular Smooth Muscle Cells
J. Biol. Chem., June 9, 2000; 275(24): 18279 - 18283.
[Abstract] [Full Text] [PDF]